← Leaderboards
Jean Y.j. Wang
Scripps Research Institute
$19,078,784
Attributed
$23,189,761
Total exposure
9
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$23,189,761 · 9
By mechanism
R01$16,320,222 · 5
T32$3,023,822 · 2
R37$2,883,921 · 1
P01$961,796 · 1
Top collaborators
- Richard D Kolodner10 shared
- Sun Ha Choo5 shared
- Christopher David Putnam5 shared
- Olivier Harismendy1 shared
Most similar at Scripps Research Institute
Same institution · by research overlap
- David A Cheresh$37,188,318
- Shuang Huang$8,283,504
- Yoshikazu Takada$4,394,224
- Richard L. Klemke$17,531,405
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsGenesResponseCell DeathIn VivoMalignant NeoplasmsProtein Tyrosine KinaseSignal TransductionMutateKnock-OutTumorDna DamageCessation Of LifeProteinsCancer CellNeoplastic CellRegulationKillingsCell ProliferationPathway InteractionsResearch StudyApoptoticGeneticMutant
Grant awards (61)
FEN1 Endonuclease as a Synthetic Lethal Target for Cancer Therapy$639,488
R01 · FY2025 · CA
FEN1-Nuclease-Targeted Therapy for Ewing Sarcoma$624,288
R01 · FY2025 · CA
Cancer Biology, Informatics & Omics (CBIO) Training Program$387,353
T32 · FY2025 · CA · contact PI
FEN1 Endonuclease as a Synthetic Lethal Target for Cancer Therapy$607,512
R01 · FY2024 · CA
FEN1-Nuclease-Targeted Therapy for Ewing Sarcoma$593,075
R01 · FY2024 · CA
Cancer Biology, Informatics & Omics (CBIO) Training Program$383,624
T32 · FY2024 · CA · contact PI
FEN1 Endonuclease as a Synthetic Lethal Target for Cancer Therapy$626,700
R01 · FY2023 · CA
FEN1-Nuclease-Targeted Therapy for Ewing Sarcoma$591,603
R01 · FY2023 · CA
Cancer Biology, Informatics & Omics (CBIO) Training Program$278,374
T32 · FY2023 · CA · contact PI
FEN1 Endonuclease as a Synthetic Lethal Target for Cancer Therapy$626,700
R01 · FY2022 · CA
FEN1-Nuclease-Targeted Therapy for Ewing Sarcoma$563,315
R01 · FY2022 · CA
Cancer Biology, Informatics & Omics (CBIO) Training Program$326,853
T32 · FY2022 · CA · contact PI
FEN1 Endonuclease as a Synthetic Lethal Target for Cancer Therapy$639,488
R01 · FY2021 · CA
FEN1-Nuclease-Targeted Therapy for Ewing Sarcoma$574,360
R01 · FY2021 · CA
Cancer Biology, Informatics & Omics (CBIO) Training Program$306,081
T32 · FY2021 · CA · contact PI
Cancer Biology, Informatics & Omics (CBIO) Training Program$334,752
T32 · FY2020 · CA · contact PI
Cancer Biology, Informatics & Omics (CBIO) Training Program$328,200
T32 · FY2019 · CA · contact PI
Nuclear Function of Abl in DNA Damage Response$387,500
R01 · FY2018 · CA · contact PI
Cancer Biology, Informatics & Omics (CBIO) Training Program$315,695
T32 · FY2018 · CA · contact PI
Nuclear Function of Abl in DNA Damage Response$387,500
R01 · FY2017 · CA · contact PI
Cancer Biology, Informatics & Omics (CBIO) Training Program$310,705
T32 · FY2017 · CA · contact PI
Nuclear Function of Abl in DNA Damage Response$387,500
R01 · FY2016 · CA · contact PI
Nuclear Function of Abl in DNA Damage Response$387,500
R01 · FY2015 · CA · contact PI
Nuclear Function of Abl in DNA Damage Response$387,500
R01 · FY2014 · CA · contact PI
Nuclear Function of Abl in DNA Damage Response$398,601
R01 · FY2012 · CA · contact PI
Biological Function of the Retinoblastoma Gene Product$72,087
R01 · FY2012 · CA · contact PI
Nuclear Function of Abl in DNA Damage Response$400,438
R01 · FY2011 · CA · contact PI
Biological Function of the Retinoblastoma Gene Product$332,126
R01 · FY2011 · CA · contact PI
Biological Function of the Retinoblastoma Gene Product$33,021
R01 · FY2011 · CA · contact PI
Nuclear Function of Abl in DNA Damage Response$414,776
R01 · FY2010 · CA · contact PI
Biological Function of the Retinoblastoma Gene Product$342,397
R01 · FY2010 · CA · contact PI
Nuclear Function of Abl in DNA Damage Response$419,984
R01 · FY2009 · CA · contact PI
Nuclear Function of Abl in DNA Damage Response$418,301
R01 · FY2009 · CA · contact PI
Biological Function of the Retinoblastoma Gene Product$342,397
R01 · FY2009 · CA · contact PI
Nuclear Function of Abl in DNA Damage Response$397,022
R01 · FY2008 · CA · contact PI
Biological Function of the Retinoblastoma Gene Product$342,397
R01 · FY2008 · CA · contact PI
Nuclear Function of the c-Abl Protooncoprotien$376,902
R37 · FY2007 · CA · contact PI
Protein Tyrosine Kinases in Leiomyomata Uteri$362,433
R01 · FY2007 · HD · contact PI
Biological Function of the Retinoblastoma Gene Product$342,397
R01 · FY2007 · CA · contact PI
Nuclear Function of the c-Abl Protooncoprotien$376,986
R37 · FY2006 · CA · contact PI
Protein Tyrosine Kinases in Leiomyomata Uteri$371,070
R01 · FY2006 · HD · contact PI
ABl tyrosine kinase in integrin dependent signal transdu$362,272
P01 · FY2006 · HL · contact PI
BIOLOGICAL Function of the Retinoblastoma Gene Product$325,631
R01 · FY2006 · CA · contact PI
Protein Tyrosine Kinases in Leiomyomata Uteri$380,000
R01 · FY2005 · HD
Nuclear Function of the c-Abl Protooncoprotein$374,952
R37 · FY2005 · CA
BIOLOGICAL Function of the Retinoblastoma Gene Product$333,694
R01 · FY2005 · CA
Protein Tyrosine Kinases in Leiomyomata Uteri$380,000
R01 · FY2004 · HD
Nuclear Function of the c-Abl Protooncoprotien$364,169
R37 · FY2004 · CA
BIOLOGICAL Function of the Retinoblastoma Gene Product$333,906
R01 · FY2004 · CA
Protein Tyrosine Kinases in Leiomyomata Uteri$380,000
R01 · FY2003 · HD
Nuclear Function of the c-Abl Protooncoprotien$353,699
R37 · FY2003 · CA
BIOLOGICAL Function of the Retinoblastoma Gene Product$334,111
R01 · FY2003 · CA
NUCLEAR FUNCTION OF THE CABL PROTOONCOPROTEIN$354,971
R37 · FY2002 · CA
BIOLOGICAL Function of the Retinoblastoma Gene Product$334,307
R01 · FY2002 · CA
TYROSINE KINASE C-ABL AND BCR-ABL IN INTEGRIN DEPENDENT SIGNALING$362,272
P01 · FY2001 · HL
NUCLEAR FUNCTION OF THE CABL PROTOONCOPROTEIN$345,647
R37 · FY2001 · CA
CELLULAR FUNCTION OF THE RETINOBLASTOMA GENE PRODUCT$255,823
R01 · FY2001 · CA
NUCLEAR FUNCTION OF THE CABL PROTOONCOPROTEIN$336,595
R37 · FY2000 · CA
CELLULAR FUNCTION OF THE RETINOBLASTOMA GENE PRODUCT$249,274
R01 · FY2000 · CA
TYROSINE KINASE C-ABL AND BCR-ABL IN INTEGRIN DEPENDENT SIGNALING$237,252
P01 · FY2000 · HL
BASIC BIOCHEMICAL AND BIOLOGICAL MECHANISMS IN CANCER$52,185
T32 · FY2000 · CA